Autonomix Medical, Inc. AMIX
Regular-session close
After hours · Nov 20, 7:33 PM ET
- YTD
- -92.28%
- 1 year
- -95.75%
5D -0.31 (-22.96%)
- Market cap
- 1.82M
- EPS (ttm)
- -12.19
- Shares out
- 1.77M
- Forward P/E
- -0.46
- YTD return
- -92.28%
- 1-year return
- -95.75%
- 50-day average
- 8.29
- Volume
- 220.18K
- Avg volume
- 2.01M
- Open
- 1.04
- Previous close
- 1.04
- Day's range
- 0.88 – 1.04
- 52-week range
- 0.8911 – 22.89
- Price target
- 28.00 (+3042.2%)
Key statistics
- 200-day average
- 26.81
- Enterprise value
- 78.74K
- Price / book
- 1.06
- Free cash flow
- -5.49M
- Total cash
- 5.16M
- Total debt
- 1.09M
- Return on equity
- -27017.08%
- Short % of float
- 2.85%
Fundamental scorecard
7 of 25 checks passed on AMIX’s reported financials
7of 25 checks passed
- Value 1 of 5
- Growth 1 of 5
- Profitability 0 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 3, 2024 | Ladenburg Thalmann | init | — | Buy |
About Autonomix Medical, Inc.
Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. It has an agreement with NoiseFigure Research, Inc. to develop next generation of its proprietary microchip. Autonomix Medical, Inc. was incorporated in 2014 and is based in The Woodlands, Texas.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- autonomix.com
News
Autonomix Highlights Renal Denervation Strategy and Vision for Illuminating the Nervous System at TCT 2026
12 Health Care Stocks Moving In Wednesday's Intraday Session
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology Autonomix Medical Will Be Issued U.S. Patent Number 12,793,841 Tomorrow Titled "MEDICAL DEVICES WITH CIRCUITRY FOR CAPTURING AND PROCESSING PHYSIOLOGICAL SIGNALS"
12 Health Care Stocks Moving In Monday's After-Market Session
Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation
Autonomix Reports Positive FDA Feedback Supporting 510(k) Pathway to U.S. Clearance
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
Autonomix Medical Announces Acceptance of Two Abstracts for Poster Presentation at CIRSE 2026
Your note
Sign in to keep a note on AMIX — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Mariner, LLC | 0.49% | 5,619 | 19.05K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.39% | 4,481 | 15.19K | Sep 29, 2024 |
| HRT Financial LP | 0.26% | 3,053 | 10.35K | Sep 29, 2024 |
| PNC Financial Services Group, Inc. | 0.16% | 1,837 | 6.23K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.10% | 1,184 | 4.01K | Sep 29, 2024 |
| Virtu Financial LLC | 0.07% | 756 | 2.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.29% | 3,296 | 11.17K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.14% | 1,589 | 5.39K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.09% | 1,035 | 3.51K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.07% | 776 | 2.63K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 347 | 1.18K | Oct 30, 2024 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 160 | 542 | Sep 29, 2024 |
